Heterocycles with Nitrogen (N)

1,1'-Carbonimidoylbis-1H-imidazole is a ligand that binds to amines and isosteres. It can be activated with electrophilic reagents to form an activated linker. This ligand has been shown to inhibit the growth of xenograft tumor cells in mice by binding to functional groups on the cell surface. This drug also has been shown to bind to the receptor for advanced glycation end products (RAGE) and inhibit its function. 1,1'-Carbonimidoylbis-1H-imidazole has also been evaluated as a cancer therapeutic agent in animal models.

Please enquire for more information about Coproporphyrin III including the price, delivery time and more detailed product information at the technical inquiry form on this page

2-Amino-6-chloropurine is a nucleophilic substituent that is used in the synthesis of 2-amino-6-chloropurine. It reacts with hydroxyl groups to form a palladium-catalyzed coupling reaction solution, which is then treated with hydrochloric acid and trifluoroacetic acid. The product is purified by crystallization and recrystallization. This compound has potent antitumor activity against carcinoma cell lines, but it has not been shown to have any effect against Mycobacterium tuberculosis.

5-Aminopyridine-3-carboxylic acid (5APC) is a structural analog of nicotinic acid that has been shown to have anti-inflammatory effects. 5APC inhibits the production of inflammatory cytokines, such as IL-10 and IL-17, by inhibiting the activation of NFκB and MAPK pathways. This drug also has significant inhibitory activities against dextran sulfate sodium (DSS)-induced acute colitis in experimental models. 5APC is thought to act by interrupting the assembly of p38 mitogen activated protein kinase (MAPK) and nuclear factor kappa B (NFκB) signaling complexes.

1-(4,4'-Difluorobenzhydry)piperazine (1-DFBP) is a potential antitumor agent that has been shown to inhibit the growth of leukemia cells. It may be an inhibitor of apoptotic cell death, as it has been shown to induce hydrogen bond formation with coumarin derivatives. 1-DFBP has also been shown to have inhibitory activities against leukemia HL-60 cells, and is a competitive inhibitor of cinnarizine. The catalytic mechanism for 1-DFBP is not known, although kinetic data suggest that it involves hydrogen bonding and/or pi stacking interactions.

Please enquire for more information about tert-Butyl6-[(1e)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-1,3-di oxane-4-acetate including the price, delivery time and more detailed product information at the technical inquiry form on this page

Sulfamethoxypyridazine is a sulfa drug that inhibits bacterial growth by inhibiting the synthesis of folic acid, which is essential for DNA and RNA production. It has been shown to be effective in the treatment of urinary infections and infectious diseases. Sulfamethoxypyridazine interacts with other drugs, such as oral contraceptives, to increase their blood levels. This drug also has a matrix effect on urine samples, which can be used to detect the presence of bacteria. The matrix effect is due to its hydrophobic nature and ability to form aggregates with other compounds. Sulfamethoxypyridazine is used in wastewater treatment plants as an analytical method for nitrogen atoms.

2-Pyrimidine-carboxylic acid is a biologically active molecule that can be found in the human body. It is a derivative of pyrimidine, which belongs to the group of purines. 2-Pyrimidine-carboxylic acid has been shown to inhibit the nicotinic acetylcholine receptor and α7 nicotinic acetylcholine receptor, which are receptors for acetylcholine. This molecule also has antihypertensive activity and has been shown to have therapeutic effects in psychotic disorders. 2-Pyrimidine-carboxylic acid binds to picolinic acid, which is an important intermediate in the metabolism of tryptophan, and hydroxyl group, which is essential for many biological functions. It also reacts with copper ions and forms a complex that is x-ray crystal structure confirmed. This complex may be used as a herbicide resistance inducer or as a chemical species for receptor binding studies or chemical reactions.

Desloratadine N-hydroxypiperidine is a drug that is used to treat allergic rhinitis and urticaria. It belongs to the class of antihistamines, which block the activity of histamine in the body. Desloratadine N-hydroxypiperidine is a prodrug that has a piperidine moiety attached to its side chain. This prodrug is metabolized into desloratadine, its active form, by esterase enzymes in the liver and blood plasma. The onset of action is rapid after oral administration and the duration of action is 12 hours or more. Desloratadine N-hydroxypiperidine has shown linearity over a wide range of pH values (pH 1 to 10) and ionic strengths (0.1 M to 0.5 M). Optimization was achieved by adjusting elution time, ion-pairing agent, mobile phase composition, organic modifier concentration and column particle

Please enquire for more information about 4-Chlorophenyl-2-pyridinylmethanol including the price, delivery time and more detailed product information at the technical inquiry form on this page

4-Hydroxypiperidine is a molecule with a carbonyl group. It is the most active and selective CCR5 receptor antagonist that has been studied to date. 4-Hydroxypiperidine inhibits HIV infection by preventing the binding of HIV to its receptor on the surface of white blood cells, thereby preventing it from entering these cells. 4-Hydroxypiperidine also acts as an anti-inflammatory agent in chronic bronchitis patients, due to its ability to inhibit prostaglandin synthesis. The chemical ionization mass spectra of this molecule show peaks for methyl ethyl, malic acid, and hydroxyl groups. These properties make 4-hydroxypiperidine a useful candidate for drug development against inflammatory diseases and several cancers.

5-Bromo-2-iodopyridine is an antibiotic that is used to treat bacterial infections. It has been shown to inhibit the growth of bacteria by binding to the 50S ribosomal subunit. This drug also has a toxic effect on respiratory system cells, which may be due to its ability to induce apoptosis. 5-Bromo-2-iodopyridine interacts with DNA in a triazine ring and inhibits bacterial growth by inhibiting protein synthesis. The drug binds to the 50S ribosomal subunit at a site that is different from that of rifampin and other antibiotics. The reaction is catalyzed by palladium at high temperatures and takes place in organic solvents such as chloroform or benzene. This synthetic process can be made more efficient by using inexpensive starting materials, such as bromine, iodine, and acetone, rather than expensive starting materials like platinum or gold salts.

2,3,5,6-Tetra-methyl-pyrazine is a chemical compound that is structurally similar to ATP. It has been shown to inhibit the mitochondrial membrane potential and induce apoptosis in rat heart cells. 2,3,5,6-Tetra-methyl-pyrazine has also been shown to inhibit ATP synthase activity and increase lactate levels in the presence of glucose. This compound inhibits cyclase activity and increases microdialysis probe signal pathways. 2,3,5,6-Tetra-methyl-pyrazine may be useful for the treatment of myocardial infarcts.

Please enquire for more information about 4,5-Dihydro-1H-imidazol-2-amine hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page

2-Bromopyrazine is a heterocyclic chemical compound that inhibits the activity of enzymes such as kinases. It has been shown to have anti-tumor properties in clinical studies and has been used in cancer research. 2-Bromopyrazine binds to nicotinic acetylcholine receptors, which are found on the surface of tumor cells. The binding of 2-bromopyrazine to these receptors causes an increase in ion flow across the membrane and leads to cell death. This drug also inhibits kinase activity, leading to decreased protein synthesis, which may account for its anti-tumor properties. 2-Bromopyrazine is soluble in organic solvents and insoluble in water. 2-Bromopyrazine is stable under acidic conditions but undergoes hydrolysis by hydrochloric acid, forming a salt and hydrogen bromide gas.

Please enquire for more information about H-Ala-Ala-Pro-OH trifluoroacetate including the price, delivery time and more detailed product information at the technical inquiry form on this page

2-(Hydroxymethyl)pyridine N-oxide is a model system that was originally synthesized to study the mechanism of perchlorate and amine degradation in vivo. It has been shown to be an excellent model for studying the oxidative decomposition of n-oxides with metal ions, as well as their transformation into monomers. 2-(Hydroxymethyl)pyridine N-oxide reacts with chloride ion to form 2-(hydroxymethyl)pyridine N-oxide chloride. The reaction of 2-(hydroxymethyl)pyridine N-oxide with a sulfoxide produces an adduct that can be used to study hydrogen bonding. 2-(Hydroxymethyl)pyridine N-oxide has biological properties and is a potential drug candidate for the treatment of cancer.

8-Chloro-3,7-dihydro-1H-purine-2,6-dione is a reactive molecule that binds to the active site of bacterial cyclic nucleotide phosphodiesterases and inhibits their activity. This inhibition prevents the breakdown of cAMP and cGMP, which are important second messengers in eukaryotic cells. 8-Chloro-3,7-dihydro-1H-purine-2,6-dione is also a potent inhibitor of protein synthesis and has been used in research studies on wheat leaves.

1-Acetylpiperazine is a growth factor that has been shown to stimulate the proliferation of keratinocytes and dermal fibroblasts. It also inhibits the production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β), in immune cells. 1-Acetylpiperazine has been shown to have antimicrobial properties against Gram-positive bacteria, including methicillin resistant Staphylococcus aureus and Clostridium perfringens. The compound binds to the receptor for epidermal growth factor in cancer cells, which may be responsible for its anticancer effects. 1-Acetylpiperazine has also been shown to inhibit the binding of imatinib to its receptor, which may be responsible for its anticancer effects.